Cannabis studies 2025: effects, health & risks

Posted on
cillustration-a-light-green-hemp-leaf-layered-in-the-middle-over-abst-

Cannabis studies 2025 on the effects, health and risks of the black market show a differentiated picture: While THC causes no impairment the following day, black market products are heavily contaminated. Long-term users also remain surprisingly healthy – as the latest data shows.

Between reality and prejudice: what we should know about cannabis today

The cannabis studies presented in this article offer new perspectives, as cannabis has long since arrived in the mainstream of society – be it for relaxation, to alleviate chronic complaints or as a natural sleep aid. And yet there are still many uncertainties and unanswered questions, such as:

– What happens to the body the next day? Am I impaired and if so, to what extent?
– Is regular consumption questionable or even dangerous?
– And how great is the risk from contaminated black market grass?

Three recent studies now provide differentiated but clear answers – and shed light on health, consumption and legislation.

🧪 Cannabis studies 2025 (1): No “hangover effect” – THC does not impair the following day

While many people consume cannabis in the evening, nobody really knows whether THC leaves noticeable residues in the body the next morning. However, an Australian research team got to the bottom of this question back in 2024 and came to a surprising conclusion:

The experimental setup:

20 participants with sleep problems – 75% of whom were inexperienced with THC – were given either a placebo or 10 mg THC + 200 mg CBD before going to sleep. The next morning, they were tested for driving behavior, concentration and subjective well-being.

What the scientists found:

  • No measurable difference to the placebo group
  • No drop in performance, no reaction delay
  • No restrictions on the ability to drive

Conclusion of the first study:

Moderate THC consumption in the evening has no effect on the following day.
This study underlines the fact that many legal sanctions – such as driving license disqualification – are scientifically untenable.

While research into effects and safety is progressing, the illegal market remains highly risky.
An analysis of around 300 black market samples from Germany and Europe shows: Only 1 in 5 samples were free of harmful substances.

🚨 Cannabis studies 2025 (2): The black market remains dangerous – 80% of cannabis is contaminated

The current publication on cannaviva.ch reports on an investigation by the Berlin-based cannabis company Sanity Group, in which over 300 samples of street cannabis from 30 German and two Swiss cities were analyzed. The results are alarming: more than two thirds of the samples contained toxic pesticides, and around 65% were contaminated with faeces, bacteria or viruses. In numerous cases, residues of other drugs such as cocaine or MDMA were also detected.

In Switzerland, the Sanity Group is active in the Grashaus Project, a pilot project approved by the FOPH for the controlled distribution of cannabis – with the aim of counteracting precisely such risks of the black market with legal, tested alternatives.

These findings highlight the urgent need for controlled supply chains to protect consumers from avoidable health risks.

  • Prohibited pesticides
  • Feces, bacteria & SARS-CoV-2
  • Hairspray, glass splinters, residues of hard drugs

Why this is so dangerous:
Many people continue to buy illegally, simply due to a lack of alternatives and a lack of consumer protection. But what is often forgotten:

➤ There are hardly any studies on extenders
➤ The state offers too few controlled sources of supply
➤ Consumers are pushed into a risk that could be avoided

How to protect yourself:
Regulated specialist stores such as Herba di Berna, certified goods and accompanying information – because health protection starts at the source. As long as the cannabis black market exists, it will remain a risk – despite studies on its effects.

📊 Cannabis studies 2025 (3): Long-term use? Not a health risk – but often even an advantage

There are clear differences, particularly in the area of cannabis health. One of the biggest surprises in terms of studies came from Spain: A long-term study with 600,000 data points was conducted there in 2024. A representative group of 419 users were examined and surveyed with regard to health, activity and mental well-being:

The cannabis studies 2025 in the area of cannabis health in particular show clear differences. One of the biggest surprises in terms of studies came from Spain: A long-term study was conducted there in 2024 with 419 test subjects – resulting in over 600,000 data points that were recorded over a period of three years:

Among other things, the following were examined:

  • General state of health
  • Body weight & BMI
  • Sleep quality
  • Taking medication before/after cannabis use
  • Mental well-being
  • Physical activity
  • Social participation
  • Form & frequency of consumption

    The core statements of the subjects administered cannabis/placebo:

    – 88 % consider their state of health to be good
    – 67 % have a normal BMI
    – 76 % are physically active every day
    – 30 % have been able to stop taking prescription medication thanks to cannabis

    A US twin study (1994-2021) with 4,000 people also confirms this:
    No connection between long-term cannabis use and mental illness.
    Conspicuous features:
    Although some people experienced sleep problems, it remains unclear whether cannabis was the cause or therapy. Similarly, 30% of those surveyed showed a slight potential for addiction – an indication of the need for responsible use.

Conclusion: Research provides clarity – now it’s up to politicians to act

These three studies clearly show:

  • Cannabis is largely harmless to health when used responsibly
  • The black market remains a health risk
  • Education, legalization and regulation are essential

What it needs now:

Pragmatic solutions that are scientifically sound and can be implemented realistically. Because cannabis use is taking place – politicians are called upon to finally create a safe framework for it.

The industry’s core demands remain unchanged:

  • Licensed specialist stores to ensure quality and the protection of minors
  • State-funded research for the differentiated assessment of effects, risks and benefits
  • Science-based legislation instead of ideologically motivated regulation

IG Hemp has formulated these approaches in detail – as a common voice of producers, specialist retailers and educational initiatives.

Consumers do not need fear – they need transparent information, tested products and a legal framework that focuses on health and education.

You want to stay informed about hemp in a correct and competent way?
Then stay up to date with the Herba newsletter:
Studies, product information & updates about CBD in Switzerland, politics & safe use – direct, clear & fact-based.
Subscribe to the newsletter now!

Cannabis Studies 2025 Sources:

  • THC does not cause a hangover effect:
    Study: “No residual effects of THC the next day”
    Link: https://link.springer.com/article/10.1007/s00213-024-06595-9
    Source: Springer – Psychopharmacology, February 2024.
  • Black market samples over 90% contaminated
    Study / Report: “Illegal cannabis products heavily contaminated – results of the Berlin Drug Checking Initiative”
    Link: https://drugchecking.berlin/ergebnisse/
    Source: Drugchecking Berlin, ongoing evaluations 2023-2024.
  • Long-term use harmless to health?
    Study: “Long-term cannabis use and physical health: no significant adverse effects in a 20-year follow-up”
    Link: https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2522790
    Source: JAMA Psychiatry, 2016 – long-term study from New Zealand.
  • Twin study:
    THC does not cause a hangover effect
    Study: “No residual effects of THC the next day
    Link: https://link.springer.com/article/10.1007/s00213-024-06595-9
    Source: Springer – Psychopharmacology, February 2024
Legal notice – This content does not constitute medical or legal advice. For health or legal concerns, please consult an appropriately qualified professional .

Edibles with CBD: health risk or health promotion

Posted on
Verschiedene Cannabis-Edibles auf einem Tisch.

A summary of the article about CBD edibles and their legislation in Switzerland by IG Hemp

Edibles with CBD, i.e. edible products with cannabidiol, are currently causing a stir. Edibles are being tested in pilot projects in Switzerland– unlike in Germany, where they are banned due to the protection of minors.

But what exactly is allowed? And what opportunities and risks do CBD foods entail and why does Switzerland exclude CBD and cannabis foods from the law?

If we take a closer look at the Swiss legislation (also discussed in more detail in our blog on hemp tea or in the Novel Food Ordinance), we quickly see that foods containing THC are classified as novel foods by the FOPH and are therefore subject to strict regulations. Nevertheless, they are currently being tested in pilot projects to better understand their effects.

According to the current legal situation, the Federal Food Safety and Veterinary Office (FSVO) classifies CBD edibles as “novel foods”. These may only be placed on the market with special authorization.

“Foods containing CBD or THC are considered novel foods in Switzerland and may only be placed on the market with the approval of the Federal Food Safety and Veterinary Office (FSVO).”
Federal Food Safety and Veterinary Office (FSVO), Art. 15 para. 1 LGV

International experience and safety concerns

Experience from Canada and the USA shows that the introduction of edibles has led to an increase in unintentional poisonings in children under the age of ten. In Canada, recommendations were therefore made to prevent such incidents.

Different legal framework conditions

In Switzerland, foods containing THC are classified as novel foods. Nevertheless, legal regulations allow THC edibles to be given to test subjects as part of pilot trials.

Calls are now being made to relax the regulations

Despite concerns, there are discussions about the sale of CBD edibles. The Maltese cannabis lobby Releaf argues that the sale of edibles containing THC in harm reduction facilities does not violate European law.

How can risks be minimized?

As overseas experience in Canada and America shows, there are potential risks associated with the sale of edibles in terms of the protection of minors. However, these can be reduced through technical ideas such as child-resistant packaging, preventative education campaigns and information on packaging. Careful regulation is crucial for successful implementation.

Conclusion

The regulation of cannabis edibles is important to establish a clear protection of minors and consumers. For this to succeed, a careful balance must be struck between health risks and the potential for harm reduction. Technical measures on packaging and comprehensive education of the public and future sales staff are essential to ensure the safety of consumers.

Sources: Cannabis edibles – health risk or “harm reduction”? – IG Hemp Switzerland

Further sources:

This article was created according to SEO guidelines to ensure optimal visibility and reader-friendliness.

CBD oil from Switzerland rediscovered in cosmetics

Posted on
Frischer Salat mit Hanfdressing aus dem CBD Shop, verfeinert mit knackigem Gemüse und Hanfsamen.
Buy CBD Switzerland

CBD oil from Switzerland in cosmetics – natural care for skin and soul

In recent years, Swiss CBD oil (cannabidiol) and cosmetics have not only found their place in the wellness and health sector, but are also increasingly conquering the cosmetics industry. What until recently was mainly consumed in the form of oils, capsules and flowers is now contained in a wide range of care products – from creams and serums to shampoos and masks. But what makes CBD so special for the skin? And how can Herba di Berna also benefit from this growing trend?

The science behind CBD in skincare

Cannabidiol (CBD) is known for its potential anti-inflammatory and antioxidant properties. These properties make it an interesting active ingredient in skincare, especially for people with sensitive skin or skin problems such as acne, dry skin and redness. Although research on CBD in cosmetics is still relatively new, there is some scientific evidence that points to potential benefits.

Anti-inflammatory and soothing

There is evidence that CBD may interact with the skin’s endocannabinoid system, which is involved in regulating processes such as cell regeneration and skin immune defense. A 2014 study suggests that CBD may have anti-inflammatory effects on the skin, making it a promising substance for skin care products aimed at reducing redness and blemishes (Olàh et al., 2014).

Link to the study: Olah et al, 2014 – CBD and acne research

Moisturizing and protective

Another feature of CBD that could be of interest for skin care is its potentially moisturizing effect. There is evidence that CBD can help to support the skin barrier, making it more resistant to external influences such as pollution. The antioxidant properties of CBD could also neutralize free radicals caused by UV radiation and air pollution, which are associated with premature skin aging (Atalay et al., 2019).

Bottle with CBD oil and drops - cosmetic use.

Link to the study: Atalay et al, 2019 – Antioxidant properties of CBD

Suitable for sensitive skin

Preliminary findings suggest that CBD could also be well tolerated by sensitive skin types. As it has no known irritant properties, unlike many synthetic ingredients, it is often used in skincare products for sensitive skin. A review of the tolerability of CBD by various research teams shows that most users have experienced no irritation or side effects, making it an interesting option for people with allergy-prone skin (Palmieri et al., 2019).

Link to the study: Palmieri et al, 2019 – Safety and tolerability of CBD

CBD oil Switzerland and cosmetics – more than just a trend?

What began as a niche product a few years ago has developed into a real boom in the cosmetics industry. Brands around the world are relying on the healing and nourishing properties of CBD and now offer a wide range of products – from anti-ageing creams to soothing facial oils.

But why is CBD so popular? The trend towards natural ingredients and sustainable cosmetics plays a decisive role. Consumers are increasingly looking for alternatives to chemical ingredients and synthetic additives. This is where CBD comes into play – as a natural, environmentally friendly and effective ingredient that fits perfectly into the philosophy of conscious skincare.

How Herba di Berna can pick up on this trend

As a company dedicated to the sustainable and organic production of high-quality hemp products, Herba di Berna already offers a range of CBD products for health and well-being. The step into the cosmetics industry has therefore already been taken.

By using organic hemp from the region and focusing on environmentally friendly production processes, Herba di Berna can play an important role in the cosmetics industry. From the development of CBD creams for dry and sensitive skin to soothing serums for after sports or against rashes – the selection is diverse.

Conclusion: Whether CBD oil Switzerland or cosmetics, the future of skincare is ?

CBD is more than just a short-term trend in the cosmetics industry. Its versatile, scientifically proven benefits make it a permanent fixture in skin care. For Herba di Berna, this is an opportunity to further harness the natural power of hemp in the cosmetics sector and meet the needs of conscious consumers with high-quality, regionally produced CBD products.

Introducing: SELECT Bud Spensary

Posted on
Hochwertiges CBD kaufen in der Schweiz – Natürliche Blüten aus nachhaltigem Anbau für Ihr Wohlbefinden.

A pioneer in the new SELECT series from Herba di Berna

Schweizer CBD-Produkte kaufen – 100% natürliche Hanfblüten von höchster Qualität.

It is with great pleasure and pride that we present Bud Spensary, an outstanding partner of our new Herba di Berna SELECT series. This collaboration marks another milestone in our journey to offer the best organic hemp products. Bud Spensary is known for sustainable cultivation and uncompromising quality that is second to none.

Sustainable hemp cultivation with Bud Spensary

Bud Spensary’s idyllic greenhouse is located in the heart of the Aargau Mittelland, directly on the Reuss river. Here, the plants are cultivated under optimal conditions that both protect the environment and guarantee the best possible quality of CBD flowers. The greenhouse is powered exclusively by sunlight – a prime example of ecologically responsible agriculture.

Biologisch angebautes CBD kaufen in der Schweiz für eine natürliche Entspannung.

Focus on sustainability Buy CBD Switzerland

Bud Spensary’s cultivation methods with the SELECT are based on a deep understanding of natural processes. Spring water and living soil form the basis for resource-conserving cultivation. The use of pesticides, herbicides and synthetic fertilizers is deliberately avoided in order to ensure a healthy environment and an unadulterated end product. If you want to buy CBD in Switzerland, you will find the best sustainable products in our SELECT series.

Quality that inspires How special CBD flowers are created

Premium CBD Blüten aus der Schweiz – sorgfältig verarbeitet für höchste Ansprüche.

The quality of Bud Spensary is not only evident in its cultivation, but also in its processing. Each plant is treated with the utmost care to ensure that the unique properties of the CBD flowers are preserved. If there’s one thing we recommend, it’s buying CBD from Swiss producers like Bud Spensary.

Drying and ripening of a CBD flower

Drying: The flowers are hung upside down and gently dried to preserve their structure and ingredients in the best possible way.

Maturing: They are then matured in special humidors. This process refines the terpene aroma and ensures an exceptional taste experience.

Thanks to continuous new breeding, Bud Spensary manages to surprise again and again with new, unique terpene profiles. This diversity makes our CBD flowers unmistakable and clearly sets them apart from the competition.

The SELECT series: sustainable innovation for CBD products

The partnership between Bud Spensary and Herba di Berna is based on shared values: quality, sustainability and a spirit of innovation. These values are the cornerstone of our SELECT range, which comprises only the best CBD products produced to the highest standards.

Buy CBD in Switzerland - Sustainable production for the highest quality.
CBD from sustainable cultivation – discover and enjoy now.

What makes the SELECT series so special:

  • Exclusivity: Only selected products make it into the SELECT series.
  • Sustainability: The focus is on environmentally friendly production methods.
  • Outstanding quality: Each flower is tested according to strict criteria to meet the highest standards.

If you want to buy high-quality CBD in Switzerland, you will find it in the SELECT series.

Why Bud Spensary is an enrichment for the SELECT series and why this CBD should be purchased in Switzerland

Bud Spensary not only brings excellent products to the SELECT series, but also an inspiring vision for the future of hemp cultivation. Through their innovation and commitment to sustainability, they are setting new standards in the industry.

Swiss CBD flowers – free from pesticides and with a full aroma

Advantages for our customers:

  • An incomparable taste experience thanks to high-quality terpene profiles.
  • Natural and gentle production without chemical additives.
  • The security of enjoying a product that is both environmentally friendly and sustainable.

CBD flowers from Bud Spensary – Buy now

Bud Spensary products are now part of our SELECT series and can be purchased both in our specialist store and in our online store.

Experience the incomparable quality and naturalness of these products and be inspired by their uniqueness. With Bud Spensary, we are setting a clear signal for quality and sustainability – true to the motto: “Keep it Organic”.

Cannabis law: abolition or adaptation? An assessment by Peter Homberg”

Posted on
Peter Homberg gibt eine Einschätzung zum aktuellen Stand des Cannabis-Gesetzes in Deutschland


Can the cannabis law be abolished so easily? According to Peter Homberg, a complete abolition of the Cannabis Act is rather unlikely. In his assessment, he explains why legal and political hurdles are making a U-turn in cannabis policy more difficult.

Cannabis law abolition Homberg’s assessment?
The political race remains exciting and is running at full speed, and the CDU has already announced its intention to repeal the Cannabis Act (CanG) if it takes over the government. We share Homberg’s assessment and according to it, this scenario is rather unrealistic. But how realistic is this scenario really? Lawyer Peter Homberg, who specializes in cannabis, has provided a well-founded assessment on krautinvest.de. Here we summarize the most important points for you.

Can the CanG be abolished so easily?
If you listen carefully to Homberg, he believes that a complete abolition of the Cannabis Act is rather unlikely. Even if the CDU were to be in government in the future, it would have to rely on a coalition partner to overturn it with at least a 50% majority – and it is questionable whether these partners would support a complete turnaround in cannabis policy. In addition, there are already numerous cultivation associations that are licensed for several years, and a withdrawal of these licenses would hardly be legally feasible.

Detailed view of a law book with cannabis leaves as a symbol for the legal development around cannabis.



Cannabis Act abolition Homberg aptly says: “You can’t get the spirit of the CanG back into the bottle completely.” However, changes could relate to details, such as the permitted amount of cannabis that can be carried or stored.

What could change for cannabis clubs?
While existing clubs would probably be protected, a new government could increase the administrative hurdles for new clubs. Restrictions on home growing or changes to the legal framework for cultivation associations would also be conceivable. Nevertheless, a complete abolition of partial legalization seems politically and legally unrealistic.

Medical cannabis: will access remain?
Another hot topic is access to medical cannabis, which is regulated by the MedCanG. Homberg sees no cause for concern here. Cannabis remains subject to prescription and will not be reclassified as a narcotic. The recent liberalization, which has made access easier for SHI patients, would make a downgrading hardly conceivable.

A notepad with legal notes and a cannabis flower that address the cannabis law.



However, there could be a possible change in telemedical prescribing practices. It remains uncertain whether doctors from other EU countries will continue to be allowed to issue prescriptions for German patients. There could be clearer regulations here in the future.

Is it cooked much hotter than it is eaten?
In fact, much of what is currently being announced in the election campaign seems exaggerated. Homberg is convinced that the actual changes – depending on the coalition partner – will be less drastic than the current threats of the conservative parties. He sees little room for major setbacks, particularly in the area of medicinal cannabis .

Herba di Berna – your partner for reliable information
At Herba di Berna, we closely follow developments in cannabis policy and are on hand to provide you with advice and support. With our expertise and personal experience, we are there for you – whether it’s about legal issues or choosing the right products. Together, we keep our finger on the pulse and ensure that you are well informed.

Stay relaxed – we’re here for you! 🌱

Source reference:
Interview with Peter Homberg on krautinvest.de, published in November 2024.

CBD and CB9: between opportunities and uncertainties

Posted on
Cannabisblüten und CBD-Öl auf einem Holztablett zur Förderung von Entspannung und Wohlbefinden


Since the ban on HHC (hexahydrocannabinol), the market for alternative cannabinoids has been in a state of flux. A new name is currently causing discussion: CB9. In contrast to well-known substances such as CBD, CB9 raises many questions – about its chemical composition, effects and legal classification.

In this article, you will find out exactly what CB9 is, how it works and what risks and opportunities are associated with it.

What is CB9 – origin, chemical structure and open questions

CB9 is advertised as a natural cannabinoid that is said to occur in the cannabis plant. However, there is no scientific evidence for this. So far, there are neither confirmed studies nor publications by renowned researchers such as Raphael Mechoulam* that mention CB9. What is particularly striking is that there is no structural chemical representation of CB9, which distinguishes it from established cannabinoids such as CBD or THC .

Nevertheless, there are assumptions. Experts assume that CB9 is a derivative of cannabidiol (CBD). This hypothesis is based on the assumption that chemical modifications of the CBD molecule lead to the observed psychoactive properties. Its formation is explained by complex chemical processes in which CBD or THC serve as starting materials. It is also striking that CB9 does not tend to crystallize, which makes it difficult to detect and highlights the need for improved testing methods.

How does CB9 work?

CB9 is described by users as mildly to moderately psychoactive. Its effect is often compared to that of HHC or delta-8-THC. Users report a calming and relaxing effect, with the psychedelic effects remaining in the background in contrast to THC or Delta-9-THC. These milder properties could make CB9 attractive to people seeking psychoactive effects but wanting to avoid possible side effects such as paranoia.

However, the quality of CB9 products varies greatly, which affects the user experience. Although products such as flowers, hashish and vapes are widely available, the fluctuating concentration and lack of chemical validation pose significant risks.



CB9 and its therapeutic potential
Despite the limited research, some scientists see promising potential in CB9. It could help relieve stress, anxiety and sleep problems. It is also being investigated whether it could play a role in the treatment of chronic pain or inflammatory diseases. However, the exact interaction with the body’s endocannabinoid system (ECS) is not yet fully understood. Initial hypotheses suggest that CB9, like CBD, binds to CB1 and CB2 receptors, but has a slightly different mode of action.

Legal gray area and challenges
CB9 is currently legal in Switzerland and Germany. This situation is reminiscent of earlier developments with synthetic cannabinoids such as Spice (Blog on synthetic cannabinoids here: Synthetic Cannabinoids – What you need to know about them ), which came onto the market in 2007 and was only later regulated. As CB9 is difficult to detect chemically and no comprehensive studies are available, it remains difficult for the authorities to create clear regulations.

These uncertainties underline the risks of an unregulated market. Consumers often do not know what they are taking, while suppliers sell products whose composition is not clearly validated. This highlights the need for a controlled and transparent cannabis market.

CB9 compared to other cannabinoids

The consequences of prohibition and the role of CB9
CB9 is another example of how prohibition brings new and often risky substances onto the market. The desire for legal alternatives cannot be suppressed by prohibition. Instead, new products are constantly being created that exploit legal gray areas. A comprehensive legalization of cannabis could break this spiral and ensure greater safety and transparency.

Herba di Berna: Your partner for quality and safety
At Herba di Berna, we focus on transparency and quality. The developments surrounding CB9 show how important it is to pay attention to reliable and tested products. We stand for a regulated market that protects consumers and offers natural products.

Our goal is not only to provide you with high-quality hemp products, but also to keep you up to date with the latest developments in the cannabis sector. Together we are shaping a safe and conscious future for cannabis. 🌱

Stay curious – we’ll keep you informed! 😊

*Raphael Mechoulam – The pioneer of cannabinoid research

Raphael Mechoulam (1930-2023) was an Israeli scientist and university lecturer who is considered one of the most important researchers in the field of medicinal cannabis. Known as the “grandfather of cannabinoid research”, he laid the foundation for today’s understanding of the cannabis plant and its medical use.

Mechoulam was Professor of Pharmaceutical Chemistry and Natural Products at the Hebrew University of Jerusalem and dedicated his life to the study of cannabis. One of his greatest discoveries was the identification and analysis of the endocannabinoid system – a network in the human nervous system that is crucial for many bodily functions such as pain, mood and sleep.

His work also convinced Israeli politicians of the benefits of medical cannabis, making Israel a pioneer in the legalization and research of cannabis. Raphael Mechoulam remains a key figure whose work has paved the way for many of today’s developments in the cannabis sector.

Sources:

Cannabis pilot projects and their current interim status

Posted on

In Switzerland, several pilot projects on the regulated sale and consumption of cannabis have been underway for some time with the aim of collecting data for a possible new legal regulation. These projects allow study participants to legally purchase and consume cannabis for recreational purposes in a controlled setting.

For example, the largest cannabis trial in Switzerland to date was launched in Zurich in May 2024. Here, around 7,500 test subjects can buy cannabis products in special sales outlets and pharmacies. They are scientifically supervised in order to record consumption and its effects. At the same time, there is a control group of 2,500 people who do not have access to legal cannabis in order to better understand differences in consumer behavior.

Basel is also running a similar project called “Grashaus Projects”, which monitors the legal sale of cannabis containing THC. The research focuses on the effects of regulated consumption and its possible health and social consequences. In addition to direct consumption data, the effects on youth protection, prevention and education are also being investigated

The SCRIPT study (Safer Cannabis – Research In Pharmacies) is investigating the legal sale of cannabis in pharmacies in Switzerland. Following the successful launch in Bern, the project was also extended to Biel and Lucerne. Participants are randomized to buy cannabis products in pharmacies either immediately or after a six-month waiting period. The aim of the study is to collect data on the safe and controlled use of cannabis , which should form a basis for future legal regulations. The study management is working closely with the cities and pharmacies to monitor and evaluate the pilot trial. The aim is to gain insights into preferred places of consumption, purchasing behavior and consumption motives.

You can find more information about the study on the official SCRIPT studywebsite.

Herba di Berna’s perspective on pilot projects and cannabis regulation

As a company committed to the healthy and responsible use of cannabis, we at Herba di Berna welcome the ongoing pilot projects in Switzerland. These studies, such as the SCRIPT study in Bern, Biel and Lucerne and the large-scale projects in Zurich and Basel, provide valuable insights into the effects of regulated cannabis use. They provide important data that will be crucial for future new legislation.

Herba di Berna supports the scientific recording of consumer behavior in a controlled environment, as it contributes to safe and informed use. Projects like these can help to destigmatize cannabis use and at the same time establish clear guidelines for prevention and youth protection.

Conclusion

The increasing number of pilot studies shows that Switzerland is on the way to transparent and controlled cannabis regulation. We see this research as a great opportunity to better understand the market and offer targeted, health-beneficial products that promote responsible consumption. We support the approach of collecting science-based data to inform policy decisions and make consumption safer and more sustainable.

Sources:

Why cannabis can affect our endocannabinoid system

Posted on

Our body has a fascinating network – the endocannabinoid system (ECS). This system is not only present in us humans, but also in almost all living beings and plays a crucial role in regulating the internal balance, the so-called homeostasis. Excitingly, the cannabis plant contains natural compounds known as phytocannabinoids, which are remarkably similar to our own endocannabinoids. This allows cannabis to connect directly to our endocannabinoid system and act on it by fitting these phytocannabinoids like “keys” into the “locks” of our ECS. This is what makes the effect of cannabis on our well-being and health so unique. This connection between the human body and the cannabis plant, both of which have similar building blocks, explains why cannabis is able to specifically influence processes such as pain perception, mood and immune reactions – an exciting interplay that we have already discussed in this blog post (blog link: Endocannabinoid system: structure, function and role) and which is explored in more depth in this blog post.

The endocannabinoid system (ECS): a deeper scientific look


The endocannabinoid system (ECS) is a complex biological network that regulates a variety of physiological processes – including pain perception, mood, inflammatory responses and even reproduction. Interest in the ECS is growing in research, as it plays a central role in the body and is relevant in the development and treatment of many diseases.

The ECS consists of three main parts that work closely together:

1. Endocannabinoids:

These are chemical substances that our body produces itself. They act like “keys” that fit into special “locks” (so-called receptors) in the body. The two most important endocannabinoids are called anandamide and 2-AG. They are only produced when the body needs them, for example when we are stressed or in pain. In this way, they help us to regain our balance.

2. receptors:

Receptors are like little “docking stations” in the body. The two most important receptors in the ECS are called CB1 and CB2. CB1 receptors are mainly found in the brain and nervous system and influence things like pain and appetite. CB2 receptors are mainly found in the immune system, where they are involved in inflammatory processes. When endocannabinoids dock onto these receptors, a reaction is triggered that can, for example, relieve pain or improve mood.

3. enzymes: To ensure that the endocannabinoids only work for as long as they are needed, the body breaks them down with the help of enzymes as soon as they have done their job. Enzymes are proteins that accelerate chemical reactions in the body. Two important enzymes, FAAH and MAGL, ensure that endocannabinoids are quickly broken down again as soon as the body no longer needs them.

How the ECS works:
The ECS helps our body to stay in balance, also known as homeostasis. You can think of it as a built-in thermostat that regulates itself up or down as required. For example, if we are stressed or injured, the ECS “switches on” processes that calm us down or reduce the pain. In this way, the ECS protects us from overload and helps us to react to external influences and remain physically balanced.

Research results on the effect of the ECS:

1. Anti-inflammatory effect: Inflammation is the body’s response to injury or infection. The ECS helps to control this inflammation via the CB2 receptors, which can be useful for joint diseases, for example.

2. pain relief: Pain is mediated by signals in the nervous system. Studies show that the CB1 receptors help to reduce the intensity of pain, which is promising for pain therapy. However, unlike with strong painkillers, cognitive functions are largely preserved.

3. appetite and metabolism: The ECS also controls our appetite and the energy we consume. Studies show that it regulates the signals in certain regions of the brain that tell us when we are hungry or full. This makes the ECS interesting for the treatment of obesity or metabolic problems.

4. protection of the brain: The ECS may be able to protect the brain from diseases such as Alzheimer’s. Studies have shown that it could have a neuroprotective effect, i.e. it protects nerve cells from damage and can therefore slow down the progression of such diseases.

5. reproduction and inheritance: The ECS even seems to have an influence on our genes. Research on mice shows that the ECS can influence the quality of sperm and possibly also alter genetic markers that are passed on to the next generation. This could offer new approaches for fertility research in the future.

How CBD supports the ECS:
CBD, a cannabinoid from the hemp plant, acts on the ECS by slowing down the breakdown of an important endocannabinoid called anandamide. This keeps it active for longer and can promote balance in the body. The special thing about CBD is that it does this without getting you ‘high’. It gently supports the ECS, helping the body to regulate itself and cope better with stress.

A look at potential future applications of the ECS:
Because the ECS is involved in so many fundamental functions, future research is likely to find new ways to target the ECS to alleviate disease or improve overall health. Particularly exciting are technologies that can target cannabinoids to specific areas of the body – for example, using specially designed nanoparticles to deliver drugs to the right place without interfering with other systems.

Sources: www.gesundheitszentrale.eu/ www.wikipedia.com

Did you know that the hemp plant contains over 113 different cannabinoids?

Posted on

Did you know that the hemp plant contains over 113 different cannabinoids? This amazing diversity is the key to a deep understanding of the effects and benefits that hemp holds for our body and mind. In this blog post, we take a closer look at the different cannabinoids contained in the plant. But also on its unique functions and the so-called entourage effect. We also share our views on why this topic is particularly important to us and why we are bringing it closer to our community.

What are cannabinoids?

Cannabinoids are chemical compounds found in the hemp plant. They interact with our endocannabinoid system, a complex network of receptors and neurotransmitters that plays an important role in regulating various bodily functions. Although CBD and THC are the most well-known cannabinoids, there are many others that are worth discovering.

The entourage effect

One exciting aspect of cannabinoids is the entourage effect. This describes the phenomenon that the various cannabinoids, terpenes and other compounds in the hemp plant act synergistically and thus enhance the overall effect. This means that the combination of these substances often produces stronger effects than isolated compounds. These synergies open up new possibilities for therapeutic applications.

The unknown cannabinoids

While CBD and THC are already the subject of intensive research, there are many other cannabinoids that are still largely unexplored. These include compounds such as CBG (cannabigerol) and CBN (cannabinol), which could show promising properties. These lesser-known cannabinoids could potentially help in the treatment of pain, anxiety or sleep disorders – but more scientific studies are needed to confirm this.

Our views

We believe that the potential of the hemp plant goes far beyond what is currently known and so we have a particular interest in bringing this to the attention of society. At a time when many people are looking for natural alternatives to conventional medicines , it is crucial to understand the full range of active ingredients in the hemp plant. It is our conviction that comprehensive research and education will not only increase knowledge about the hemp plant, but also revolutionize its use in health promotion.

Why are we reporting on this?

  1. Knowledge is power: We want to give you the opportunity to make your own informed decisions about the use of hemp products, but also to know what they do to your body. By sharing knowledge about lesser-known cannabinoids, we hope to highlight the benefits for health and well-being.
  2. Educating people about natural alternatives: In a world where many people are looking for natural cures , it is important to highlight the versatility of the hemp plant. We believe that it can be a valuable alternative to conventional treatments.
  3. Promoting open discussion: We want to provide a platform where our community can ask questions and initiate discussions about the application and research of hemp products. Open communication is the key to better understanding.
  4. Supporting research: By emphasizing the importance of further studies on unknown cannabinoids, we want to raise awareness of the need for scientific research. Every step towards more knowledge can expand the potential of hemp.

Conclusion:

We believe that the hemp plant is an impressive natural product that has far more to offer than just CBD and THC. The diversity of cannabinoids and their interaction within the entourage effect opens up exciting prospects for the future of health promotion. Stay tuned as we continue to explore the secrets of this amazing plant and share our knowledge with you!

Do you have any questions or want to know more about a specific cannabinoid? Let us know and share it with you!

or subscribe to our exciting newsletter to stay up to date.

Source Medcan.ch

Survey evaluation and analysis by IG Hemp and U Weed on the consumption of CBD by the Swiss population

Posted on

Who consumes CBD in Switzerland? – Insights from a national survey

In recent years, interest in CBD has grown enormously in Switzerland and Europe. Many consumers are discovering the positive effects of the natural active ingredient extracted from the cannabis sativa plant. Awareness of the potential benefits of cannabidiol, or CBD for short, is growing steadily, particularly with regard to relaxation, pain relief and stress reduction. To find out more about CBD consumers in Switzerland, IG Hemp conducted a survey in collaboration with the online CBD store uWeed. The results provide fascinating insights into the profiles and preferences of Swiss CBD users.

Who are the Swiss CBD consumers?

The study included 1170 participants, representing a cross-section of CBD consumers in Switzerland. One of the most important results: A majority of respondents use CBD primarily to relieve stress and relax. More than 50% of survey participants say they use CBD for relaxation, while 46% use it to help them sleep better. Others use CBD for pain relief (26%) or to alleviate psychological stress such as anxiety or depression (14%). A smaller proportion of participants use CBD specifically to relieve symptoms of chronic conditions.


High level of education, but not high earnings

It is interesting to note that many Swiss CBD users are better educated than average. Almost 41% of participants have a university or college degree – significantly more than the national average of around 31%.

However, this does not mean that this group is particularly high-income. Around 40% of respondents earn less than CHF 50,000 per year, and only 16% have an income of over CHF 100,000. These figures also reflect the young average age of consumers: over half of the participants are between 18 and 40 years old, and only 22% are over 50.

This illustration underlines that a high level of education does not necessarily correlate with a high income, especially among CBD consumers in Switzerland.

The graph on the left shows the proportion of participants with a university or college degree (41%) compared to the national average of 31%. The graph on the right shows the income distribution:

  • 40% of respondents earn less than CHF 50,000 per year.
  • Only 16% earn an income of more than CHF 100,000 per year.

Gender-specific differences in CBD consumption

One striking point is that men use CBD significantly more often than women. Two thirds of the survey participants were male, which indicates that men are leading the way in this market. The study also shows that men are more likely to be long-term users: More than a third of the male participants have been consuming CBD for more than two years, while almost half of the women have only been at it for less than six months. There are also gender-specific differences in the preferred products: While men often reach for CBD flowers, women tend to opt for CBD oil.

Here is the chart showing the gender differences in CBD consumption in Switzerland. The left graph shows the gender distribution among CBD users:

  • 66% of consumers are male.
  • 34% of consumers are female.

The chart on the right shows the duration of use by gender:

  • 33% of men consume CBD for more than two years.
  • 50% of women have only been using CBD for less than six months.

These differences show that men tend to start using CBD earlier and women are more likely to be newcomers to this market.

Online shopping and information procurement

Most CBD consumers in Switzerland prefer to shop online: 74% order their products online. This is not least due to the increased use of online shopping since the start of the pandemic. Of these, 58% buy on multi-brand platforms, 35% directly from individual brands and 6% on marketplaces such as Amazon or Galaxus.

The way in which information about CBD is obtained also varies between the sexes. While men tend to rely on online sources such as specialist blogs and social networks, women rely more often on recommendations from their personal environment. The study also shows that consumers mainly look for information about the health benefits of CBD and the effects of the various products.

At Herba di Berna you will also find many blog posts on the website where you can find professional information about the consumption of CBD in its various forms. The specialist store on Scheibenstrasse is also always the place to go for non-binding advice on oils, flowers and other methods of taking CBD and what to look out for.

Which products do Swiss consumers prefer?

Swiss CBD consumers primarily prefer CBD flowers and oils. Both products are very popular, but differ in their style of use: flowers are often smoked or vaporized, resulting in a quick, intense effect, while CBD oil offers a milder, longer-lasting effect. Interestingly, flower users are more likely to consume it in social settings, while oil tends to be used alone. These differences show that the choice of product depends not only on the desired effect, but also strongly on the respective social context.

CBD as an alternative to THC?

Another aspect that the survey sheds light on is the relationship of CBD users to THC, the psychoactive component of the cannabis plant. Over half of the participants do not consume any illegal substances, followed by cannabis products containing THC. Of those who use both, 74% stated that they also use tobacco, and almost half occasionally use illegal cannabis. Should THC one day be legalized in Switzerland, more than half of users would still retain CBD as a supplement or even as a substitute.

Conclusion

The survey by IG Hemp and uWeed shows that CBD is already established in many areas of life in Switzerland. Consumers are well informed and pay attention to the quality of the products. Despite the growing interest, the market remains in flux, especially as the profile of users continues to diversify. Whether as a means of relaxation, to alleviate ailments or as an alternative to THC – the demand for CBD products is likely to continue to grow in the future.

Further information on the consumption habits and needs of CBD consumers in Switzerland can be found in the full report by IG Hanf und uWeed【Quelle】.